• LAST PRICE
    6.8400
  • TODAY'S CHANGE (%)
    Trending Up0.4500 (7.0423%)
  • Bid / Lots
    6.6000/ 1
  • Ask / Lots
    6.9900/ 200
  • Open / Previous Close
    6.6400 / 6.3900
  • Day Range
    Low 6.5300
    High 6.9450
  • 52 Week Range
    Low 5.0100
    High 12.7500
  • Volume
    315,178
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 6.41
TimeVolumeCMPS
09:32 ET81316.75
09:34 ET79536.77
09:36 ET111476.685
09:38 ET15006.67
09:39 ET20006.609
09:41 ET3006.55
09:43 ET23116.56
09:45 ET46796.7135
09:48 ET8886.6424
09:52 ET25586.64
09:54 ET6206.6244
09:56 ET2006.655
09:57 ET22726.78
09:59 ET9006.78
10:01 ET19276.7489
10:03 ET6436.7
10:06 ET1006.705
10:10 ET2106.69
10:12 ET1006.68
10:14 ET78886.7301
10:15 ET4006.745
10:17 ET4006.7
10:19 ET9056.73
10:24 ET1006.72
10:26 ET4006.7207
10:28 ET14006.7
10:30 ET1006.7
10:32 ET3126.718
10:33 ET1006.7
10:35 ET25246.755
10:37 ET24156.8
10:39 ET16366.795
10:42 ET1006.78
10:44 ET4406.79
10:46 ET1006.76
10:48 ET1006.767
10:50 ET42946.82
10:51 ET28006.82
10:53 ET3006.8209
10:55 ET23566.84
10:57 ET9006.825
11:00 ET6146.83
11:04 ET2006.81
11:08 ET10506.84
11:11 ET39436.89
11:15 ET4056.9
11:18 ET5006.8732
11:20 ET20286.91
11:24 ET3006.91
11:26 ET18076.92
11:27 ET3006.92
11:29 ET5106.915
11:33 ET64746.9085
11:36 ET1006.833
11:38 ET2006.82
11:40 ET2356.84
11:42 ET135456.895
11:44 ET1006.9
11:45 ET15596.93
11:47 ET10196.92
11:49 ET4006.93
11:51 ET1006.925
11:58 ET2006.87
12:00 ET4006.89
12:03 ET8246.9
12:05 ET6496.905
12:07 ET5346.905
12:09 ET4006.89
12:14 ET5006.86
12:16 ET2506.8639
12:18 ET3446.87
12:20 ET4206.89
12:21 ET6356.89
12:23 ET86326.82
12:25 ET1006.87
12:27 ET1006.8609
12:30 ET5006.82
12:32 ET2506.8
12:34 ET26806.81
12:36 ET8806.8453
12:38 ET4016.825
12:41 ET1006.79
12:43 ET3056.8
12:45 ET37956.85
12:48 ET5006.8637
12:50 ET1506.85
12:52 ET1006.8374
12:54 ET1006.87
12:57 ET2006.84
12:59 ET7506.85
01:01 ET26006.91
01:03 ET1506.905
01:06 ET3946.905
01:08 ET13506.8798
01:15 ET1016.8701
01:24 ET1006.84
01:28 ET30106.9149
01:35 ET2006.881
01:37 ET1006.9199
01:39 ET12006.89
01:42 ET2186.87
01:44 ET31006.8777
01:46 ET14236.87
01:48 ET6006.92
01:50 ET14596.861
01:53 ET2006.89
01:55 ET4006.92
01:57 ET7006.92
02:00 ET4086.87
02:02 ET1506.9
02:04 ET7296.93
02:06 ET1006.94
02:08 ET5006.89
02:09 ET3226.9
02:11 ET3006.89
02:13 ET1006.91
02:15 ET25366.86
02:18 ET21386.89
02:24 ET1006.89
02:27 ET3006.89
02:29 ET17286.902
02:31 ET3006.91
02:33 ET102896.86
02:36 ET3066.87
02:38 ET7306.89
02:40 ET112266.89
02:44 ET26856.85
02:45 ET2066.8316
02:47 ET2006.85
02:49 ET3166.7801
02:51 ET7006.7701
02:54 ET2906.8329
02:58 ET44336.82
03:00 ET1006.84
03:02 ET5006.87
03:03 ET3006.85
03:05 ET20506.86
03:07 ET1006.84
03:09 ET1606.8599
03:12 ET5106.8799
03:14 ET1006.8859
03:16 ET3006.89
03:18 ET19766.92
03:20 ET15696.93
03:21 ET1006.94
03:23 ET14546.93
03:25 ET11706.89
03:30 ET16006.85
03:32 ET29666.84
03:34 ET10706.8589
03:36 ET23446.82
03:38 ET8996.84
03:39 ET1506.8301
03:41 ET8006.81
03:43 ET14846.81
03:48 ET7846.81
03:50 ET9396.85
03:52 ET52216.85
03:56 ET16006.86
03:57 ET54496.855
03:59 ET249766.84
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCMPS
Compass Pathways PLC
447.9M
-2.9x
---
United StatesALXO
ALX Oncology Holdings Inc
451.7M
-2.3x
---
United StatesTERN
Terns Pharmaceuticals Inc
452.1M
-5.9x
---
United StatesLENZ
LENZ Therapeutics Inc
454.3M
-1.2x
---
United StatesALT
Altimmune Inc
443.8M
-4.0x
---
United StatesKRRO
Korro Bio Inc
435.7M
-1.0x
---
As of 2024-06-12

Company Information

Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Contact Information

Headquarters
3Rd Floor, 1 Ashley RoadALTRINCHAM, United Kingdom WA14 2DT
Phone
---
Fax
---

Executives

Interim Independent Chairman of the Board
David Norton
Chief Executive Officer, Executive Director
Kabir Nath
Chief Financial Officer, Principal Accounting Officer
Teri Loxam
General Counsel, Chief Legal Officer
Matthew Owens
Chief Medical Officer
Guy Goodwin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$447.9M
Revenue (TTM)
$0.00
Shares Outstanding
68.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.32
EPS
$-2.37
Book Value
$3.64
P/E Ratio
-2.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.